GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+18.82%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$337M
AUM Growth
+$337M
(-1.3%)
Cap. Flow
-$37.8M
Cap. Flow
% of AUM
-11.21%
Top 10 Holdings %
Top 10 Hldgs %
43.87%
Holding
79
New
19
Increased
11
Reduced
20
Closed
23
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$17.5M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$10.4M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$9.46M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$7.76M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$15.5M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.2M |
| 3 |
Puma Biotechnology
PBYI
|
$10.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
$8.38M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$8.27M |
Sector Composition
| 1 | Healthcare | 80.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $27.2M | 5.78% | 1,946,946 +746,946 | +62% | +$10.4M |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $21M | 4.47% | 600,000 +500,000 | +500% | +$17.5M |
|
|
DBVT
3
DBV Technologies
DBVT
$264M
| $17.9M | 3.79% | 420,886 -4,114 | -1% | -$175K |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $14M | 2.98% | 100,000 | – | – |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $13.8M | 2.93% | 225,000 +75,000 | +50% | +$4.6M |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $13.1M | 2.77% | 350,000 +260,000 | +289% | +$9.7M |
|
|
NVRO
7
DELISTED
NEVRO CORP.
NVRO
| $10.5M | 2.22% | 115,000 -50,000 | -30% | -$4.54M |
|
|
ENTL
8
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $10.4M | 2.2% | 561,510 +186,510 | +50% | +$3.44M |
|
9
Insmed
INSM
$28.8B
| $10.1M | 2.15% | 324,400 -150,600 | -32% | -$4.7M |
|
|
AVXS
10
DELISTED
AveXis, Inc. Common Stock
AVXS
| $10.1M | 2.15% | 104,539 -85,461 | -45% | -$8.27M |
|
|
11
Thermo Fisher Scientific
TMO
$186B
| $9.46M | 2.01% | +50,000 | New | +$9.46M |
|
|
GNMK
12
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.15M | 1.94% | 950,000 +125,000 | +15% | +$1.2M |
|
13
Zimmer Biomet
ZBH
$21B
| $8.78M | 1.86% | 75,000 -5,000 | -6% | -$585K |
|
14
Boston Scientific
BSX
$156B
| $8.02M | 1.7% | 275,000 +100,000 | +57% | +$2.92M |
|
|
15
Puma Biotechnology
PBYI
$254M
| $7.78M | 1.65% | 65,000 -85,000 | -57% | -$10.2M |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $7.76M | 1.65% | +250,000 | New | +$7.76M |
|
17
Vertex Pharmaceuticals
VRTX
$100B
| $7.6M | 1.61% | +50,000 | New | +$7.6M |
|
18
Ascendis Pharma
ASND
$11.8B
| $7.25M | 1.54% | +200,000 | New | +$7.25M |
|
|
ONCE
19
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $7.13M | 1.51% | 80,000 +45,000 | +129% | +$4.01M |
|
20
iRhythm Technologies
IRTC
$5.46B
| $7M | 1.49% | 135,000 -15,000 | -10% | -$778K |
|
|
RXDX
21
DELISTED
Ignyta, Inc.
RXDX
| $6.79M | 1.44% | +550,000 | New | +$6.79M |
|
|
PDCO
22
DELISTED
Patterson Companies, Inc.
PDCO
| $6.18M | 1.31% | +160,000 | New | +$6.18M |
|
23
argenx
ARGX
$43.6B
| $5.71M | 1.21% | 252,534 +56,247 | +29% | +$1.27M |
|
24
Neurogene
NGNE
$264M
| $5.68M | 1.21% | 400,000 +100,000 | +33% | +$1.42M |
|
|
NSTG
25
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.58M | 1.19% | 345,284 -4,716 | -1% | -$76.2K |
|